- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2025 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Pharmaceutical Technology-06-02-2008
Pharmaceutical Technology
Antibody Drug Conjugates: A Marriage of Biologics and Small Molecules
June 02, 2008
Ingredients Insider
32
6
Antibody drug conjugates offer a niche opportunity in drug development and contract manufacturing.
Healthcare Reform Proposals Challenge Manufacturers
June 02, 2008
Washington Report
32
6
Comparative-effectiveness analysis aims to promote appropriate pharmaceutical spending.
The Use of Complaining
June 02, 2008
Agent-In-Place
32
6
Customers complaining lead to some serious explaining.
Biopharmaceutical Manufacturing: The Challenge of Global Regulatory Compliance
June 02, 2008
Peer-Reviewed Research
32
6
The author provides an overview of key regulatory issues facing companies seeking to market their biopharmaceutical agents globally.
PDA Takes On Risks for Patients
June 02, 2008
PharmTech Talk
32
6
Risk management, and its benefits for patients, plays a big role at the PDA Annual Meeting.
Cell Manufacturing on a Large Scale
June 02, 2008
Special Report
32
6
Creating a kinder, gentler manufacturing process that doesn't kill the product is the goal of process developers doing large-scale cell culture for cell therapy.
In the Spotlight June 2008
June 02, 2008
In the Spotlight
32
6
Editors' Picks of Pharmaceutical Science & Technology Innovations
Innovations at INTERPHEX: Part 2
June 02, 2008
Online Exclusive
32
6
New products for sterile filling, quality control, and anticounterfeiting measures gained notice.
Small Wonder: Nanoparticle Strategies for Biological Drugs
June 02, 2008
Special Report
32
6
Nanoparticle-based systems present many advantages for the delivery of current and emerging biological drugs.
Toward a New Model for Contract Manufacturing
June 02, 2008
Outsourcing Outlook
32
6
Global manufacturing excellence will be a game changer for CMOs that can achieve it.
Report from: India
June 02, 2008
News
32
6
With rising drug deveopment costs and burdensome clinical trials, Indian-based firms are transferring their research departments to other entities in hopes of saving cash, mitigating risk, and ultimately, buying back the rewards.
Contamination Prevention: How Single-Use Systems Can Ensure a Safe, Clean, and Efficient Bioprocess Environment
June 02, 2008
Online Exclusive
32
6
The authors focus on how single-use systems effectively control three potential sources of common contamination: cross contamination, microbial contamination and biologic contamination of the process facility.
Can Transparency=Trust?
June 02, 2008
Viewpoint
32
6
Letting the public inside the drug development process may increase their faith in what we do.
A Broad Palette for Biological Drug Delivery
June 02, 2008
Online Exclusive
32
6
Although the spotlight is now on nanoparticulate delivery for biologicals, other strategies have proven successful.
Variability of USP Lot P Prednisone Reference Standard Tablets
June 02, 2008
Articles
32
6
The authors demonstrate that anecdotal reports of prednisone tablet variability are inaccurate.
Public Service Versus Self-Service
June 02, 2008
From The Editor
32
6
The good, the bad, and the ugly about direct-to-consumer advertising.
Coming Down the Pike: Endocannabinoids
June 02, 2008
News
32
6
Scientists are uncovering signaling systems that operate via cannabinoid messenger molecules.
Preformulation in Theory and Practice
June 02, 2008
Online Exclusive
32
6
An ambitious survey of characterization techniques presents current information.